For the quarter ending 2026-04-04, USNA made $250,218K in revenue. $7,515K in net income. Net profit margin of 3.00%.
| Income Statement | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Net sales | 250,218 | 226,200 | 213,670 | 235,848 |
| Cost of sales | 59,436 | 49,408 | 48,815 | 50,184 |
| Gross profit | 190,782 | 176,792 | 164,855 | 185,664 |
| Brand partner incentives | 88,654 | 91,535* | 77,684 | 87,040 |
| Selling, general and administrative | 88,254 | 78,081 | 85,947 | 81,906 |
| Impairment | - | 1,742* | - | - |
| Cost realignment | - | 1,616* | - | - |
| Total operating expenses | 176,908 | 172,973 | 163,631 | 168,946 |
| Earnings from operations | 13,874 | 3,819 | 1,224 | 16,718 |
| Interest income | 437 | 495 | 578 | 619 |
| Interest expense | 240 | 123 | 49 | 259 |
| Other, net | 1,394 | -14 | 41 | 1,739 |
| Other income (expense), net | 1,591 | 358 | 570 | 2,099 |
| Earnings before income taxes | 15,465 | 4,177 | 1,794 | 18,817 |
| Income taxes | 8,506 | 5,772 | 8,456 | 8,373 |
| Net earnings | 6,959 | -1,595 | -6,662 | 10,444 |
| Net (loss) earnings attributable to redeemable noncontrolling interest | -556 | 180 | -140 | 789 |
| Net earnings attributable to usana | 7,515 | -1,775 | -6,522 | 9,655 |
| Basic EPS | 0.41 | -0.097 | -0.36 | 0.52 |
| Diluted EPS | 0.41 | -0.097 | -0.36 | 0.52 |
| Basic Average Shares | 18,398,000 | 18,285,000 | 18,293,000 | 18,513,000 |
| Diluted Average Shares | 18,411,000 | 18,382,000 | 18,293,000 | 18,536,000 |
USANA HEALTH SCIENCES INC (USNA)
USANA HEALTH SCIENCES INC (USNA)